Lindbrook Capital, LLC Atrion Corp Transaction History

Lindbrook Capital, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 25, 2024	SELL	$308.3 - $463.55 $616 - $927	-2 Reduced 40.0%	3 $1,000
Q4 2023 Jan 31, 2024	SELL	$289.29 - $409.7 $4,628 - $6,555	-16 Reduced 76.19%	5 $1,000
Q3 2023 Oct 25, 2023	BUY	$401.2 - $581.79 $8,024 - $11,635	20 Added 2000.0%	21 $8,000
Q2 2023 Jul 28, 2023	BUY	$500.0 - $659.0 $500 - $659	1 New	1 $0
Q3 2022 Nov 10, 2022	SELL	$545.43 - $680.3 $2,181 - $2,721	-4 Reduced 80.0%	1 $1,000
Q2 2022 Aug 01, 2022	SELL	$605.0 - $763.25 $1,210 - $1,526	-2 Reduced 28.57%	5 $3,000
Q1 2022 Apr 21, 2022	SELL	$601.4 - $763.0 $601 - $763	-1 Reduced 12.5%	7 $5,000
Q4 2021 Jan 18, 2022	BUY	$650.15 - $802.0 $650 - $802	1 Added 14.29%	8 $6,000
Q2 2021 Jul 27, 2021	BUY	$582.88 - $670.99 $4,080 - $4,696	7 New	7 $4,000

114K

Ticker ATRI
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 1,785,990
Description
Atrion Corporation, together with its subsidiaries, develops, manufactures, and sells products for fluid delivery, cardiovascular, and ophthalmology applications in the United States, Canada, Europe, and internationally. Its fluid delivery products include valves that fill, hold, and release controlled amounts of fluids or gasses for use in vari...

Get notified when there are updates to the investment portfolio of Lindbrook Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Lindbrook Capital, LLC with notifications on news.